NewsBenzingaJP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30 JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30 Benzinga 2026.10.01 14:45 (GMT+0) Open on Benzinga Other news A Nearly $12 Billion AI Deal Could Be Another Reason to Buy Nvidia Stock Ultrapar Participações S.A. (UGP) Analyst/Investor Day - Slideshow (NYSE:UGP) 2026-10-03 Bill Ackman Says He Can Size Up a CEO's Character in an Hour Macro Conditions May Mean A Period Of No Growth Lies Ahead OpenAI safety employee resigns, claiming the company’s ‘culture is broken’ The Real Moon Trade Isn't Who Gets There First — It's Who Keeps the Base Running
